Palisade Asset Management’s Zimmer Biomet ZBH Stock Holding History

Palisade Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-714	Closed	-$70.3K	–	691
2025 Q3	$70.3K	Buy	+714	New	+$70.8K	0.01%	252
2024 Q2	–	Sell	-900	Closed	-$119K	–	403
2024 Q1	$119K	Buy	+900	New	+$112K	0.01%	222
2021 Q4	–	Sell	-1,545	Closed	-$220K	–	185
2021 Q3	$220K	Hold	1,545	–	–	0.03%	179
2021 Q2	$241K	Hold	1,545	–	–	0.03%	172
2021 Q1	$240K	Sell	1,545 -144	-9%	-$22.3K	0.03%	169
2020 Q4	$253K	Buy	1,689 +144	+9%	+$20.3K	0.03%	170
2020 Q3	$204K	Buy	+1,545	New	+$202K	0.03%	168
2020 Q1	–	Sell	-1,573	Closed	-$229K	–	181
2019 Q4	$229K	Buy	1,573 +28	+2%	+$3.87K	0.03%	172
2019 Q3	$206K	Buy	+1,545	New	+$200K	0.03%	167
2019 Q2	–	Sell	-1,648	Closed	-$204K	–	174
2019 Q1	$204K	Buy	+1,648	New	+$187K	0.03%	172

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Palisade Asset Management's ZBH Position: Q4 2025 in Review

Palisade Asset Management sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 714 shares — an estimated $70.3K sold.

Palisade Asset Management first reported a position in ZBH in Q1 2019 and held it in 10 quarters. The position peaked at $253K in Q4 2020. 949 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

Palisade Asset Management reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
Palisade Asset Management sold 714 Zimmer Biomet shares in Q4 2025, an estimated $70.3K.
Palisade Asset Management first reported a position in Zimmer Biomet in Q1 2019 and held it in 10 quarters.
Palisade Asset Management's Zimmer Biomet position peaked at $253K in Q4 2020.
949 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Palisade Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.